QIAGEN Reports Full Q3 2026 Results
Business Wire•04/11/2026•16:05 ET
0
Key Highlights
- ➤Q3 sales $548 million, up 3% YoY and 3% at constant exchange rates
- ➤Adjusted diluted EPS $0.65, exceeding outlook for at least $0.62 CER
- ➤Adjusted operating margin 30.4%, up 0.8 percentage points YoY
- ➤QIAGEN suspended 2026 outlook pending EQT Private Equity transaction
* Net sales of $548 million rise 3% and also 3% at constant exchange rates (CER)
Adjusted operating income margin of 30.4% rises 0.8 percentage points
Get started
Create a free account to read the full story.